Rhein Bio is set to undergo a significant ownership change, transferring control to Guangzhou Defu Nutrition, aiming to enhance growth and market presence in the health sector.

Target Company Overview

Rhein Bio, a company focused on producing natural health products, has announced a significant change in its ownership structure. Effective December 24, 2025, Guangzhou Defu Nutrition Investment Partnership will become the controlling stakeholder. The current controller, Qin Benjun, has entered into an agreement to sell 8.09% of his shares to Guangzhou Defu while also relinquishing 25.50% of his holdings. Post-transaction, he will retain a 3% voting power in the company, ensuring some level of influence over its operations.

Prior to the deal, Rhein Bio was suspended from trading, having last traded at ¥8.70 per share, with a market capitalization of ¥64.52 billion. The transition is marked by an impressive 23.68% premium over the last closing price, with shares being sold at ¥10.76 each. Once the deal is finalized, Guangzhou Defu will hold 8.09% of the company and will also gain voting rights related to an additional 11.17% of shares.

Industry Overview in China

The health and wellness sector in China has been experiencing remarkable growth, fueled by increasing consumer demand for natural and organic products. As consumers become more health-conscious and aware of the benefits of nutrition, companies in this sec